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Abstract: In cattle, conceptus-derived interferon tau (IFNT) is the pregnancy recognition (PR)
signal. Our previous studies showed that non-cytopathic bovine viral diarrhoea virus (ncpBVDV)
infection inhibited IFNT-induced interferon stimulated gene (ISG) expression, potentially causing
early embryonic death. This study investigated the effect of bovine viral diarrhoea virus (BVDV)
infection on upstream regulatory pathways of ISG production using an established PR model. Uterine
endometrial cells from 10 apparently healthy and BVDV free cows were cultured and treated with
0 or 100 ng/mL IFNT for 24 h in the presence or absence of ncpBVDV infection. Microarray and
pathway analysis were used to determine the IFNT-induced upstream regulators. Expression of the
genes associated with the identified pathways were quantified with qPCR. IFNT challenge activated
the signalling pathways associated with IFN receptors, JAK1/TYK2, IRFs and STATs and ncpBVDV
infection inhibited the activation of IFNT on this pathway. Inhibition of this upstream signalling
pathway may thus reduce ISG production to disrupt maternal PR. In addition, the reduction of uterine
immunity by ncpBVDV infection may predispose the animals to uterine infection, which in turn
impairs their reproductive performance. This provides a mechanism of how BVDV infection leads to
early pregnancy failure in cows.
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1. Introduction
In cattle populations, embryonic mortality rates can reach up to 40% [1,2]. Between 2000 and
2006, a decline in reproductive performance was estimated to cause losses of up to £100 per cow
per year in the United Kingdom [3,4]. The causes are complicated and not entirely understood [5,6].
Pregnancy recognition (PR) failure is one important cause for embryonic death and poor reproductive
performance. The majority of embryonic mortality (70–80%) occurs before day 16, when maternal
PR takes place [1,7–9]. Failure of PR in a timely fashion will be followed by regression of the corpus
luteum, which will in turn causes loss of the embryo.
Interferon tau (IFNT) is released from the trophectoderm of the bovine conceptus between about
days 8–25 of gestation. When it reaches a sufficient threshold by day 16, maternal PR (MPR) is
initiated, including maintenance of the corpus luteum and development of a receptive environment
in the uterus [10]. IFNT acts in a paracrine manner on the uterine endometrium in concert with the
continued production of luteal progesterone to cause various changes in type I interferons, cytokines,
prostaglandins (PGs) and growth factors and their receptors, which play important roles in remodelling
the endometrium and developing a receptive environment for conceptus implantation [8,10–13]. Among
these factors, type I interferon stimulated genes (ISGs) play crucial roles [11]. During IFNT-initiated
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MRP, numerous uterine genes (over 500) were differentially expressed with the greatest upregulation
attributed to a group of pregnancy-specific ISGs [8,10,12,13]. The mechanisms determining how these
ISGs act on MPR in vivo and implantation are not fully understood, but it has been suggested that
upregulation of ISG production plays a crucial role in the modulation of uterine immunity, stromal
remodelling, stimulating hyperplasia of the endometrial glands and development of the uterine
vasculature [11,14].
There is strong evidence to suggest that bovine viral diarrhoea virus (BVDV) infection can disrupt
pregnancy. BVDV is a positive sense single stranded (SS) RNA virus belonging to the genus Pestivirus
and family Flaviviridae. Despite the introduction of control and eradication programmes in some
countries, it remains endemic worldwide with major economic impact [15–18]. A systematic review
using data derived from 15 countries for a period of 30 years showed that the direct losses were up
to 687 USD per animal with higher losses of around 25 USD in naïve dairy than in beef cows [19].
Reproductive losses are one of the consequences of this disease. BVDV infection affects all stages of
pregnancy, especially the early period [15,20,21].
BVDV exhibits vertical transmission from mother to foetus, potentially resulting in the birth of a
persistently infected (PI) calf, which can subsequently spread the disease amongst the herd. Infection
between animals is generally via the oronasal route, but direct transmission to the reproductive tract
via semen or embryo transfer is also possible. Once acquired, the virus has a broad tissue tropism,
and can replicate in many tissues, including the female reproductive system [20,22]. In support of
this, our recent studies using an in vitro model of PR illustrated that BVDV inhibited bovine uterine
defence systems to facilitate its own survival [23,24]. As expected, IFNT treatment alone significantly
stimulated ISG expression in endometrial cell cultures, but concurrent BVDV infection significantly
inhibited this stimulatory effect for 15 of the 17 ISGs tested (ISG15, HERC5, USP18, DDX58, IFIH1,
IFIT1, IFIT3, BST2, MX1, MX2, RSAD2, OAS1Y, SAMD9, GBP4 and PLAC8) [24]. This suggests a
potential mechanism by which BVDV infection impairs PR and reproductive performance.
ISG transcription is regulated by IFNT induced pathways involving a signal transducer and
activator of transcription (STAT) 1 and STAT2. IFNT binds to a common type I IFN receptor composed
of interferon alpha and beta receptor subunit 1 (IFNAR1) and subunit receptor 2 (IFNAR2) subunits.
This initiates cell signalling via the Janus activated kinases (JAKs) and tyrosine kinase 2 (TYK2)
pathways [25,26]. This pathway allows phosphorylation of STAT1 and STAT2 which dimerise and the
subsequent formation of interferon stimulatory gene factor 3 gamma (ISGF3G) which includes the
STAT1:STAT2 heterodimer and interferon regulatory factor 9 (IRF9). ISGF3G can then travel to the
nucleus and activate interferon stimulated response elements (ISREs), inducing the transcription of
ISGs [27].
In the present study, we wished to determine how ncpBVDV infection could prevent the
upregulation of ISG within uterine endometrial cells in response to the PR signal IFNT. We, therefore,
focussed on intracellular signals known to be initiated following activation of the type 1 IFN receptor
in the endometrium. This involved the pathway of JAK/TYK2-IRF-STAT1 and STAT2 which acted as
upstream regulators of ISG synthesis.
2. Materials and Methods
Reagents and consumables were purchased from Sigma-Aldrich (Poole, Dorset, UK) or Thermo
Fisher Scientific (Paisley, UK) unless otherwise stated. All culture media contained 50,000 units/L
penicillin and 50 mg/L streptomycin and were certified BVDV free. BVDV free foetal bovine serum (FBS;
PAA, Somerset, UK) was used for the cell isolation and culture. Cell isolation and culture procedures
were carried out under sterile conditions. The cells were cultured at 37 ◦C with 5% CO2.
2.1. Animals, Cell Isolation and Culture
Fresh and apparently health uteri from cows in the early luteal phase of their oestrous cycle were
collected at the local abattoir. Potential BVDV contamination was tested with a PCR method used in our
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laboratory with the primer pair: forward (5’-ATGCCCWTAGTAGGACTAGCA-3’; position 108–128)
and reverse (5’-TCAACTCCATGTGCCATGTAC-3’; position 395-375) [23,28] and a BVDV-positive
control prepared using the pT7Blue-2 blunt vector, linearized (Novagen, Cambridge, MA02139,
USA). The expected sequence covered the highly conserved 5′ non-coding/non-structural coding
regions of the pestivirus BVDV genome strain NADL [28]. The testing system also included a
reverse-transcription-negative control and a reference gene ACTB (see Table 1 for its primers). The uteri
from 10 BVDV-free cows were selected for the experiments.
Table 1. Oligonucleotide primer sequence information.
Gene Primer Sequence (5′-3′) GenBankAccession
Product
Length (bp)
Annealing
(◦C)
ACTB Forward: GAAATCGTCCGTGACATCAAReverse: AGGAAGGAAGGCTGGAAGAG NM_173979.3 182 62.8
GAPDH Forward: GGTCACCAGGGCTGCTTTTAReverse: TTCCCGTTCTCTGCCTTGAC NM_001034034.2 147 61.4
RPL19 Forward: TCGATGCCGGAAAAACACReverse: ATTCTCATCCTCCTCATCCAG NM 001040516 119 59
18SrRNA Forward: CGGCGACGACCCATTCGAACReverse: GAATCGAACCCTGATTCCCCGTC AY779625 99 64.5
IFNAR1 Forward: CATGTCAGTGTTGGTGCTTCAGReverse: ACACAATACACAGTCAGCGGTT NM_174552.2 173 60.2
IFNAR2 Forward: AAAAGTGGCTACCGTGGAAGTCReverse: TGAAGTGGTGGAAGTTGGACAC NM_174553.2 169 60.2
IRF7 Forward: AAGTGCAAAGTCTACTGGGAGGReverse: CAAGTAGATGGTGTAGTGCGGG XM_015461322.1 180 60.2
JAK1 Forward: TGAGAACGAGTGTCTTGGGATGReverse: GGTGAGAAGGTTCCTCTGTCTG XM_010803450.2 154 62.8
PIAS2 Forward: CCGAGAATTGTATAGACGCCGAReverse: AGAGGACGGAGAATGAGGTGTA XM_010825599.2 178 61.4
TYK2 Forward: GAAGTTCCCTATCGAGCTCCAGReverse: GTGTGACGATGAGGTTGGAGAT XM_005208739.3 185 62.8
IRF9 Forward: TACCATCAAAGCGACCCCACReverse: AAGTCTAAACGGCCAGCTCC XM_010808904.2 151 60.2
STAT1 Forward: GTCTCAATGTGGACCAGATGAReverse: TCATTCCAGAGAGCAAGCAGG XM_005202573.3 187 60.2
STAT2 Forward: TCCTGCTGCGCTTTAGTGAAReverse: TCCTCCGTGAGCATCTGGTA XM_005206561.3 169 62.8
IFNG Forward: ATGCAAGTAGCCCAGATGTAGCReverse: CTCAGAGCTGCCATTCAAGAAC NM_174086.1 215 62.8
Uterine endometrial cells (a mixture of primary epithelial and stromal cells) were isolated and
cultured using the methods established in our laboratory [23,24]. Briefly, strips of intercaruncular
endometrium were dissected and put into Dulbecco’s Modified Eagle’s Medium/Nutrient Mixture
F-12 Ham (DMEM/F12 medium) (Sigma). They were cut into 1 mm3 cubes using a mechanical tissue
chopper (McIIwain Laboratory Engineering, Guilford, Surrey, UK). About 40 g of the chopped tissue
was mixed with 60 mL digestive solution split into two 50 mL sterile vials. The digestive solution
contained 100 mg bovine serum albumin (BSA, Sigma), 50 mg trypsin III (Worthington, Lakewood,
NJ 08701, USA) and 50 mg collagenase A (Roche, Welwyn Garden City, UK) per 100 mL of Hanks’
balanced salt solution (HBSS; Sigma). After incubation for 90 min at 37 ◦C with 5% CO2 with manual
mixing every 30 min, the cell suspension was filtered through 100 µm mesh into 50 mL falcon vials
containing 10% FBS and 3 µg/mL trypsin inhibitor (Sigma) with HBSS added to 50 mL and centrifuged
at 100× g at 10 ◦C for 10 min. After two repeats of the aforementioned washing procedures, the cells
were suspended with the culture medium (DMEM/F12 medium with 10% FBS) and plated in 24-well
IWAKI micro plates (Scitech DIV, Asahi Techno Glass, Japan) at 2 mL per well containing 0.5 × 105 cells
(day 1). Culture medium was changed every 48 h to allow the cells to grow. Contamination of immune
cells was determined by immunocytochemical staining validated in our laboratory [29].
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2.2. Experimental Protocols
The ncpBVDV (Pe515nc strain) was isolated from a cow diagnosed with mucosal disease and
virologically cloned as non-cytopathogenic virus by the BVDV Research Group (Royal Veterinary
College, UK). The virus stock was propagated to achieve a 50% tissue culture infective dose (TCID50)
of 5 × 105 per ml following the method previously used in our group [30]. Cells from each cow were
grown in two 24-well plates as described previously (day 1), one for ncpBVDV infection and another
for a non-infected control, to prevent cross-contamination. The BVDV inoculation was carried out on
day 4 of the cell culture when the cells reached about 70% confluence. To infect the cells with ncpBVDV,
the wells were inoculated with medium containing Pe515nc BVDV at a multiplicity of infection (MOI)
of 0.1 for 3 h in 0.25 mL of maintenance medium (MM, DMEM/F12 medium with FBS reduced to 5% to
prevent overgrowth of the cells). For the cells designated as the non-infected controls, 0.25 mL MM
was added to each well following the aforementioned procedures. The volume in all wells was made
up to 1 mL with MM and the medium was changed after two days. IFNT treatment was carried out
4 days after infection (day 8). For the wells specified for IFNT treatment, the medium was replaced
with 1 mL MM containing 100 ng IFNT (recombinant ovine IFNT, Cell Sciences, Canton, USA) and
incubated for 24 h. Thus, the cells from each cow were taken as a batch and subjected to four treatments:
Control (CONT), IFNT, ncpBVDV and ncpBVDV+IFNT. The cells from each treatment group in each
cow (6 wells) were pooled for total RNA extraction using RNeasy Mini kits (Qiagen, Manchester, UK)
following the supplier’s protocol and stored at –80 ◦C for PCR and qPCR assays. Another set of the
treated cells were lysed with Buffer RLT (Qiagen) and stored at –80 ◦C for STAT2 protein assay.
2.3. Assessment of BVDV Cell Infection and Cell Viability
The ncpBVDV infection in bovine endometrial cells was assessed using the PCR method with
the extracted RNA (see above) and an indirect enzyme immunostaining as described previously [30].
After the cells were exposed to all treatments, their viability was estimated with an MTS reduction
assay following the supplied protocol [29].
2.4. Primer Design and PCR
In this study, conventional PCR was used to check specificity of the primers and to produce
the gene amplicons for preparing standard curves used in the absolute qPCR. DNA sequences for
all primers were obtained for GenBank (https://www.ncbi.nlm.nih.gov/gene/) and the primers were
designed using a Primer3 version 4.1.0 (http://bioinfo.ut.ee/primer3/). The primer sequence information
is shown in Table 1. The primers were made by Eurofins Genomics (Ebersberg, Germany).
The amplicon length (100–200 bp) and melting temperature (around 60 ◦C) were optimized
according to the recommendation by PCR Biosystems (London, UK) who supplied the reagents for
cDNA synthesis (RT) and qPCR. The alignment specificity and quality were confirmed with the Blast
tool (https://www.ncbi.nlm.nih.gov/tools/primer-blast/).
The potential genomic DNA contamination in the RNA extract was eliminated with RQ1
RNase-Free DNase kit (Promega Corporation, Madison, WI, USA) based on the supplied protocol. 1 µg
of the treated RNA was reverse transcribed into cDNA using a cDNA synthesis kit (PCRBiosystems,
London, UK) according to the supplier’s protocol. To minimize potential variation, a mastermix of
reagents were made and all samples and standards were accommodated in a single PCR plate under the
same conditions. The resulting cDNA was diluted to 100 µL. The conventional PCR for the candidate
genes was carried out using the method and reagents described previously [24]. One proportion of the
resulting product was subjected to electrophoresis on a 2% (w/v) agarose gel to confirm the primer
specificity and another proportion was purified using a QIAquick PCR purification kit (Qiagen) for
preparation of the standard curve and annealing temperature optimization, used in the qPCR assay.
The concentration and quality of the purified cDNA was determined with a NanoDrop ND 1000
spectrophotometer (NanoDrop, Technologies Inc, Wilminton, DE, USA).
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2.5. Microarray Hybridization and Analysis
To identify the upstream regulation of the ISG signalling pathways, the extracted RNA from the
cells treated with IFNT and CONT in four cows per group were selected for microarray hybridization
using the Affymetrix Bovine Gene 1.1 ST platform (Affymetrix, Santa Clara, USA) following the
methods described previously [29]. Microarray hybridization and scanning were performed in
Edinburgh Genomics (The Roslin Institute, University of Edinburgh, Easter Bush, Midlothian, UK)
using a one-round amplification (one-cycle target labeling) protocol with the GeneTitan instrument
(Affymetrix) following their protocols (http://genomics.ed.ac.uk/resources/protocols). The data were
processed and analyzed with GeneSpring GX software V12.5 (Agilent Technolgy, Santa Clara, USA)
using the annotation files provided. RMA16 with quantile normalization and median polish was used
for background correction, normalization and summarization. Samples were paired within the same
cow and a paired t-test with p-values adjusted via Benjamini–Hochberg false discovery rate was used
to compare the differences between the treatment groups. Statistical significance was considered at
p < 0.05. The genes with an absolute fold change > 1.25 between the IFNT and CONT groups were
selected for further analysis.
2.6. Ingenuity Pathway Analysis
The differentially expressed genes identified in the aforementioned microarray analysis were
uploaded onto the server of Ingenuity Pathway Analysis (IPA; Qiagen) to map to the genomic database
and to analyse the upstream regulation and networks. The criteria uploaded included gene symbols,
fold changes and adjusted p values.
2.7. qPCR Analysis for Gene Expression
Based on the results generated in the aforementioned upstream regulation and network analyses,
10 target genes (IFNAR1, IFNAR2, STAT1, STAT2, IFR7, IFR9, JAK1, TYK2, PIAS2 and IFNG) and
4 potential reference genes (GAPDH, RPL19, ACTB and 18SrRNA) were selected for expression
quantification using the methods described previously [24]. Before qPCR assay, the optimal annealing
and amplicon-specific melting temperature were determined using the gradient function built in the
qPCR system (CFX96 Real-Time qPCR, Bio-Rad Laboratories). There were eight identical reactions
containing 0.25 ng of the DNA standard, 10 µL SyGreen Mix (PCRBiosystems), 0.8 µL of each, 10 µM
forward and reverse primer and nuclease-free water added up to 20 µL in each reaction. We used an
absolute qPCR approach for quantification of the gene expression, in which each assay included a
standard curve with eight concentrations ranging from 1 to 1 × 10−7 ng/mL, no template control (NTC)
and sample cDNA from RT. All these were prepared in duplicate and fitted into one PCR plate (StarLab,
Milton Keynes, UK) with the same mastermix of reagents. Two step amplification was used based on
the recommendation by the qPCR reagent supplier (PCRBiosystems). Each qPCR reaction contained
5 µL of standard, sample cDNA or nuclease-free water (NTC), 10µL SyGreen Mix (PCRBiosystems),
0.8 µL of 10 µM forward and reverse primer and 3.4 µL nuclease-free water. The qPCR assay was
carried out in a Bio-Rad CFX Real-Time qPCR system (Bio-Rad, Hercules, USA), including a Tag
activation at 95 ◦C for 2 min, 38 cycles of denaturing at 95 ◦C, and annealing/extension for 30 s at
the optimized temperatures listed in Table 1. This was followed by melting curve analysis to check
the quality of the qPCR assays. The results were analyzed using the CFX Manager Software package
(Bio-Rad). The limit of quantification was 1 × 10−6 to 1 × 10−7 ng/mL for all tested genes.
2.8. STAT2 Protein Assay
The cell lysate from three wells of the same treatment was collected and pooled with a volume of
0.6 mL after the treatments. A proportion of lysate (0.1 mL) was further diluted 20 times and centrifuged
at 4 ◦C and 10,000× g for 20 min. The supernatants were collected for determining STAT2 protein
using an enzyme-linked immunoassay (ELISA) kit purchased from Insight Biotechnology (Middlesex,
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UK) following the supplier’s protocol. The total proteins in the cell lysates were determined with a
NanoDrop ND 1000 spectrophotometer. The concentration was normalized to pg/mg protein.
2.9. Statistical Data Analysis
The mRNA expression values were expressed as fg/µg RNA. The four quantified house-keeping
genes were loaded to GeNorm software (Ghent University Hospital Centre for Medical Genetics,
Belgium). The gene with the smallest M values was selected as the stable gene. Analysis of variance
(ANOVA) was carried out to test the differences in HK gene expression (as identified with GeNorm)
between groups. The results showed that GAPDH was the most stable gene, therefore, the expression
values of all target genes were normalized to the expression values of GAPDH as the target gene/GAPDH,
described previously [24]. The experiment was based on a randomized block design, in which the
cells isolated and cultured from each cow were subjected to all treatments (CONT, BVDV, IFNT and
BVDV+IFNT) and 10 cows (batches) were used. Statistical data analysis was carried out for each
gene separately using ANOVA via a linear mixed effect model built in SPSS 25 (Chicago, IL, USA),
in which the four treatments were set as fixed effect and cow (batch) as random effect. The diagnostic
plots for this model are provided in File S2 and the variance components in File S3. The level for
statistical significance was set to p < 0.05. A significant difference was shown in ANOVA, Fisher’s
Least Significant Difference (LSD) multiple comparisons were carried out to determine the differences
between each treatment pair. Levene’s test was carried out to assess the homogeneity of variances
across the groups. The results showed that the variances of IFNAR2 and IFNG were not homogeneous
(File S4). The homogeneity could not be achieved with logarithmic and Box-Cox transformation.
The data for these two genes were, therefore, analyzed using Welch’s ANOVA with Games-Howell
multiple comparison.
3. Results
3.1. Validation of Cell Culture and BVDV Infection
Examination with PCR showed that all uteri selected for the present study were free of BVDV
infection/contamination. For the groups ncpBVDV and ncpBVDV+IFNT, the cultured cells were
successfully infected with the BVDV virus as confirmed with PCR and immunocytochemistry that
was described previously [30]. The MTS reduction assay illustrated that no treatments altered the
cell viability. We measured the expression of vimentin (VIM, a marker for stromal cells) and keratin
19 (KRT19, a marker for epithelial cells) in the treated cells and the results showed that both VIM
(55704 ± 9052 fg/µg RNA) and KRT19 (16945 ± 2262 fg/µg RNA) were well expressed in the cultured
endometrial cells. There were no significant differences in expression of these genes or their ratios
between all treatment groups (CONT, ncpBVDV, IFNT and ncpBVDV+IFNT) (p > 0.05) as tested with
ANOVA. This indicated that there were reasonable populations of both endometrial epithelial and
stromal cells in our cell culture systems and that neither ncpBVDV nor IFNT affected the cellular
growth and population. Contamination of immune cells in the cultured cells was negligible (< 0.001%).
3.2. Identification of Upstream Regulatory Pathways
With the criteria set up above, the analysis showed that there were 214 differentially expressed
genes (DEG) between the IFNT and CONT groups (p < 0.05) (See File S1 for the complete list).
These DEG were uploaded onto the IPA server for (i) network and (ii) upstream regulation analysis.
The system built over 10 networks. Figure 1 shows Network 1 which centered on the interferon
regulatory factors (IRF7, IRF9 and ISGF3), STAT1 and STAT2. This was the most significant network
identified with 25 focus molecules and a score of 45. Figure 2 illustrates two canonical pathways
constructed by IPA, which illustrates the position of those DEG which were known to feature in the
IFN type 1 and type 2 signalling pathways.
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Figure 1. Network 1 showing STAT1 and STAT2—IRF signalling pathways in bovine endometrium
which play central roles in regulating IFNT-initiated ISG production. The endometrial cells were
isolated from freshly collected uteri of apparently healthy cyclic cows (n = 4) and cultured to confluence.
The cells were challenged with 0 or 100 ng/mL IFNT for 24 h on day 8 of the cell culture. RNA was
extracted from the treated cells and subjected to microarray hybridization using Affymetrix Bovine
Gene 1.1 ST platform. The DEGs were uploaded onto the IPA for network analysis. The network is
displayed graphically as nodes and edges (the biological relationship between expression of genes:
red—upregulated, green—downregulated in IFNT vs. CONT in endometrial cells). The fold value
(IFNT: CONT) and p values are indicated under each node. The shapes of nodes indicate the functional
class of the gene product as shown in the key.
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Figure 2. Canonical pathways showing the position of DEGs within interferon signalling pathways
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The IPA upstream regulator analysis is based on prior knowledge of expected effects between
transcriptional regulators and their target genes. It examined how many known targets of each
transcription regulator were present in our dataset, and also compared their direction of change. This
analysis identified over 200 potential upstream regulators, in which the top upstream regulators were
associated with the ISG regulatory pathway of IRF-STAT1 and -STAT2 (Table 2). Their activation led to
the production of many ISGs.
Table 2. Selected top upstream regulators for the genes identified in File S1, which were differentially
expressed between the control cells and those treated with IFNT *.
Upstream Regulator Predicted Activation State Activation z-Score p-Value
IRF7 Activated 5.344 7.22 × 1033
IFNA2 Activated 4.958 8.72 × 1026
IFNL1 Activated 4.439 2.62 × 1025
IFNAR Activated 4.415 8.00 × 1024
ACKR2 Inhibited −3.742 9.89 × 1022
IFNG Activated 5.923 2.76 × 1019
TRIM24 Inhibited −4.186 5.34 × 1019
Interferon alpha Activated 4.914 2.10 × 1017
IFN Beta Activated 3.938 8.29 × 1017
TLR3 Activated 2.959 1.29 × 1016
IRF3 Activated 4.155 8.61 × 1016
IRF1 Activated 4.185 9.64 × 1016
MAPK1 Inhibited −4.482 1.15 × 1015
IRF5 Activated 3.528 4.26 × 1015
EIF2AK2 Activated 3.687 4.68 × 1014
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Table 2. Cont.
Upstream Regulator Predicted Activation State Activation z-Score p-Value
DDX58 Activated 2.481 8.59 × 1014
DNASE2 Inhibited −2.200 4.94 × 1013
NKX2-3 Inhibited −4.359 5.42 × 1013
STAT2 Activated 2.567 2.50 × 1012
STAT1 Activated 3.970 2.91 × 1012
IFNA1/IFNA13 Activated 3.258 3.40 × 1012
IFN Activated 3.397 2.84 × 1011
IFNAR1 Activated 2.592 5.57 × 1011
PAF1 Activated 3.000 1.78 × 1010
IRF9 Activated 1.951 4.50 × 1010
STAT3 Activated 1.506 7.44 × 1010
PARP9 Activated 2.425 1.51 × 109
IFN type 1 Activated 2.047 1.71 × 109
IFNAR2 Activated 2.236 2.99 × 109
UBA7 Inhibited −1.992 2.33 × 108
PTGER4 Inhibited −2.137 1.11 × 107
TGM2 Activated 2.514 2.08 × 107
DOCK8 Activated 2.828 2.74 × 107
TICAM1 Activated 3.120 2.86 × 107
IRF2 Inhibited −1.597 1.99 × 106
IL1B Activated 3.057 3.16 × 106
ISGF3 6.41 × 105
JAK1 Activated 2.219 3.71 × 105
STAT6 Inhibited −0.956 1.78 × 104
* The upstream regulators were selected according to the activation z-score, p values derived from Fisher’s exact
test and the relevance. The endometrial cells were isolated from freshly collected uteri of apparently healthy cyclic
cows (n = 4) and cultured to confluence. They were challenged with 0 or 100 ng/mL IFNT for 24 h on day 8 of the
cell culture. RNA was extracted from the treated cells and subjected to microarray hybridization using Affymetrix
Bovine Gene 1.1 ST platform. The DEGs were uploaded on to IPA for upstream regulator analysis. The Z-score is a
statistical measure of the match between expected relationship direction and observed gene expression.
3.3. Determination of Reference Genes for Normalization
The effect of ncpBVDV, IFNT and their combination on the selected reference genes was determined
with the absolute qPCR method and the results showed that all four selected reference genes were
highly expressed in the cultured bovine endometrial cells. ANOVA showed that expression of ACTB,
RPL19 and 18SrRNA was significantly affected by either IFNT or ncpBVDV treatment. GAPDH was,
however, stably expressed between the treatment groups and GeNorm analysis showed that it had the
smallest M values among the four tested reference genes. Therefore, the expression values of all ten
candidate genes were normalized to GAPDH for the subsequent comparison of the treatment effects.
3.4. Effect of IFNT Alone on Candidate Gene Expression
Treatment with 100 ng/mL IFNT for 24 h significantly increased the expression of IFNAR2, TYK2,
STAT1, STAT2, IRF7, IRF9 and IFNG (p < 0.05-p < 0.001), however, did not alter the expression of
IFNAR1 or PIAS2. JAK1 expression was numerically higher than in the CONT cells but this failed
to attain statistical significance (p > 0.05). The concentration of STAT2 protein was also significantly
increased (p < 0.01) (Figures 3 and 4).
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Figure 3. Effect of ncpBVDV, IFNT and their co bination on expression of the genes associated with
JAK/TYK2-STAT1 and STAT2–IRF signalling pathways in uteri e endometrial cells in cows, measured
with qPCR and normalised to GAPDH as described in the Methods. The columns labe ed with different
letters were significantly different and the p values are indicated in the graph for each gene.
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Figure 4. Effect of ncpBVDV, IFNT and their combination on the production of STAT2 protein measured
with ELISA in lysates of the cul ured bovine uterine endometrial cells eated with CONT and IFNT in
the absence and pr sence of cpBVDV infection. The conce tration was normalized to pg/mg protein.
a > b and a > c, p < 0.01; b > c, p < 0.05.
3.5. Effect of BVD Alone on Candidate Ge ression
Treatment with Pe515nc BVDV for 5 days significantly increased the expression of TYK2 and IFNG
(p < 0.05), but did not alter the mRNA expression of IFNAR1, IFNAR2, JAK1, STAT1, STAT2, IRF7, PIAS2
or the concentration of STAT2 protein. Expression of IRF9 was reduced (p < 0.05) (Figures 3 and 4).
3.6. Effect of BVDV on IFNT-Treated Cells
For all seven genes whose expression was increased by IFNT alone, the presence of BVDV infection
prevented this rise (IFNAR2, TYK2, STAT1, STAT2 (both gene and protein), IRF7, IRF9 and IFNG)
(p < 0.05–0.01). The combined treatment also reduced the expression of IFNAR1 and PIAS2 and the
conce tration of STAT2 protein in compar son with the control cultu es (a l p < 0.05). JAK1 expression
was not altered (Figures 3 and 4).
4. Discussion
Upregulation of uterine ISG production by IFNT released from the conceptus trophectoderm is a
vital component of maternal PR in ruminants [11]. This effect has been observed both in vivo [8] and
in vitro [24]. BVDV infection disrupts various stages of pregnancy, including early pregnancy (PR and
implantation) [20]. Our previous studies showed that ncpBVDV infection inhibited or neutralised the
stimulatory effect of IFNT on ISG production [24]. The ISG signalling pathway is controlled by its
upstream regulatory pathway: JAK/TYK2-STAT1 and STAT2–IRFs. Our present results demonstrated
that, in the uterine endometrial cells, IFNT treatment upregulated the genes at various levels of the
JAK/TYK2-STAT1 and STAT2 –IRF signalling pathways, including IFN receptors, JAK1/TYK2, IRFs
and STATs. Microarray and pathway analyses showed that these pathways played a central role in
IFNT-initiated MPR in cows. Infection with ncpBVDV inhibited the activation of IFNT on this pathway.
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This provides part of the mechanism by which BVDV infection leads to PR failure in cows and is
summarised in Figure 5. It should be noted that our results were obtained after 24 h stimulation with
IFNT, thus, only represents one time point. During pregnancy recognition IFNT production by the
conceptus begins around day 8 of gestation and terminates around day 25, once the corpus luteum
has been maintained and implantation has begun [31]. The endometrial cells are therefore exposed
continuously to IFNT for a 17-day period, which is likely to represent a differing situation to the
induction of other type 1 interferons during an infection.
The JAK/TYK2-STAT-IRF signalling pathway is involved in many processes including immunity,
cell division, cell death and tumor formation [32,33]. Its activation also leads to up-regulation of many
ISGs required for MPR to develop a receptive environment in the uterus [11]. This pathway does
not usually function autonomously but is regulated by various intrinsic and environmental stimuli.
Activation starts with IFNT binding to the type I IFN receptor complex composed of IFNAR1 and
IFNAR2. We found here that IFNT challenge stimulated IFNAR2 but not IFNAR1 mRNA expression,
although in a previous study Forde et al. [8] did not observe differential expression of either the INF
receptor subunit in a microarray comparison of uterine endometrium between cyclic and pregnant
cows on Day 16 (See their File S2). Treatment with ncpBVDV alone did not affect mRNA expression of
either receptor subunit but the stimulatory effect of IFNT was inhibited in the presence of ncpBVDV
infection. As STAT—activating cytokine receptors lack intrinsic tyrosine kinase activity, they require
receptor-associated cytoplasmic proteins from JAKs and TYK2 to fulfil their functions, including
IFNT-induced phosphorylation, formation of intracellular tyrosine residues on the receptor and
formation of STAT docking sites [32]. In the present study, both ncpBVDV infection and IFNT alone
significantly stimulated TYK2 mRNA expression but this did not happen when both treatments were
combined, indicating potential disruption of MPR at this level of the pathway. Neither ncpBVDV
infection nor IFNT alone altered JAK1 mRNA expression. It was reported that JAK1 mRNA expression
on day 16 was slightly lower in pregnant than in cyclic cows (see Forde et al. File S2) [8]. Together
this indicates that TYK2 rather than JAK1 is the possible target for both ncpBVDV and IFNT at this
level of the pathway in bovine endometrium. It should be noted, however, that in the present study
the samples were collected five days after the BVDV infection was introduced and 24 h after IFNT
challenge. The experimental protocol was, therefore, not designed to detect the immediate direct
effects of either treatment on these signalling pathways, such as phosphorylation of JAK1 and TYK2.
Within this timeframe secondary effects were likely to have occurred, which may have led indirectly to
the changes in gene expression which were detected.
IRFs regulate the transcription of IFNs and ISG expression and the signalling pathway of Toll-like
receptors and collaborate with other co-acting transcription factors such as nuclear factor-kappaB
(NF-kappaB). They bind DNA and exert their activating potential as homo- or heterodimers. They can
form complexes with STATs to activate the key steps of the JAK-STAT-IRF signalling pathway [32].
During the MPR on day 16 of pregnant cows, IRF7 and IRF9 mRNA expression in uterine endometrium
was upregulated by about six-fold compared with the cyclic cows [8], suggesting their important roles
in maternal PR. Inhibition of IRF-dependent transcriptional regulatory mechanisms is associated with
many immune diseases [34]. In the present study, we tested the effect of ncpBVDV infection and IFNT
challenge on the expression of IRF7 and IRF9 mRNA. Consistent with the aforementioned in vivo
study, IRF7 and IRF9 mRNA expression were both significantly induced by IFNT treatment. However,
in the presence of ncpBVDV infection, the stimulatory effect of IFNT disappeared. Disruption of this
upstream regulatory pathway of ISG signalling may affect MPR. In addition, in the cells infected with
ncpBVDV alone, expression of IRF7 was slightly reduced and that of IRF9 was significantly inhibited.
Reduced expression of the IRFs may lead to decreased innate immunity, which could predispose cows
to uterine infections which in turn might impair their reproductive performance [34,35].
STAT1 and STAT2 play central roles in the JAK/TYK2-STAT-IRF signalling pathway. After
phosphorylation on both IFNAR receptors and the STAT proteins by JAK1 and TYK2 in the cytoplasm,
STAT1 and STAT2 together with IRF9 formed a regulatory complex–IFN-stimulated gene factor 3
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(ISGF3). ISGF3 enters the nucleus and binds to DNA to cause transcription of many ISGs [32] (Figure 5a).
We investigated the expression of STAT1, STAT2 and IRF9 in the File S2 of the previous report [8] and
found that all of them were significantly upregulated in bovine endometrium during maternal PR.
Our present data agreed with the aforementioned in vivo results, as both STAT1 and STAT2 genes
and STAT2 protein were significantly upregulated by IFNT challenge in bovine uterine endometrial
cells. However, ncpBVDV infection suppressed the stimulatory effect of IFNT. Phosphorylation of
the STAT proteins is a necessary component of this pathway. This was not investigated in the present
study, however, it would be interesting to determine in future whether this step was influenced directly
by ncpBVDV. It was also reported that STAT1 exerts its effect on promoting ISG production via an
ubiquitin ligase complex PARP9-DTX3L, which targets host histone H2BJ and viral 3C protease to
control viral infection [36]. In the present study, IFNT challenge increased the expression of both
PARP9 and DTX3L by up to six-fold (p < 0.01) in bovine uterine endometrial cells compared with the
cells without IFNT challenge (See File S1) and PARP9 was identified as an upstream regulator for ISG
production. This suggested that the PARP9-DTX3L pathway may also play a role in MPR.
Protein inhibitors of activated STATs (PIAS) are a group of ubiquitin-like modifiers, which add a
marker to many genes, including JAKs and STATs, leading to their inhibition [37]. They act to control gene
expression and are considered as transcriptional co-regulators [38]. PIAS1 and PIAS2 play key roles
in the pathogenesis of autoimmune and inflammatory diseases [39]. In our present study, ncpBVDV
alone moderately increased the expression of PIAS2 mRNA. This was expected as ncpBVDV may
upregulate production of the inhibitors of the JAK/TYK2-STAT-IRF signalling pathway to block its
activation. It was not, however, expected that the combination of ncpBVDV with IFNT would reduce
PIAS2 expression significantly compared with the other three groups as this might, in theory, increase
production of ISGs whereas our previous study showed that this combination inhibited the production
of most ISGs we tested [24]. The decrease in PIAS2 production was possibly not effective enough to
offset the inhibitory effect of ncpBVDV on IFNT-induced gene expression or some other yet unknown
mechanisms were involved.
In our present study, the IFNT-induced JAK/TYK2-STAT1 and STAT2-IRF signalling pathways
were significantly inhibited in the presence of ncpBVDV infection. Its downregulation not only
inhibited production of the ISGs required for both PR and antiviral signalling, however, would also be
expected to disrupt other immune mechanisms within the uterus. Our previous study demonstrated
that IFNT challenge stimulated the ISG-production to develop a pro-immune and antiviral environment
in the uterus whereas ncpBVDV inhibited this stimulatory effect [24]. There are at least five main
effector pathways of IFN-mediated antiviral responses as identified by a gene target study and ISGs
have been shown to play crucial roles in four of them [36,40]. Activation of these pathways can
block viral transcription and translation, degrade viral RNA and modify protein function to control
all steps of viral replication [40]. In addition, the inhibition of IRF-dependent pathways disrupts
NF-κB signalling and many other immune mechanisms and is associated with reduced immunity and
increased susceptibility to bacterial infections [34]. Thus, by inhibiting those immune mechanisms,
ncpBVDV can evade host detection and destruction to facilitate its own proliferation, maintenance
and spreading, and increase the likelihood of a secondary bacterial infection, such as Escherichia coli or
Trueperella pyogenes, thus becoming established in the reproductive system [29,30,41].
Many previous studies have investigated how infection with pestiviruses, including BVDV,
can cause immunosuppression [42]. BVDV has a viral RNase Erns glycoprotein, which inhibits
IFN expression induced by extracellular viral RNA and an Npro site to promote the degradation
of the transcription factor IRF3 [42–45]. This prevents synthesis of type 1 IFNs as illustrated in
Figure 5a. Our data are in accord with this, as the comparison of gene expression profiles between
control endometrial cells and those treated with ncpBVDV alone failed to find evidence for increased
expression of any type 1 interferon genes present on the array (IFNAA, IFNA16, IFNAH, IFNB1, IFNB3)
in response to the virus [30]. In contrast to our results, however, previous studies have concluded
that although there is clear evidence showing that infection with ncpBVDV can block the induction of
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type 1 IFN synthesis, the action of IFN is not compromised [42]. For example, Schweizer et al. [46]
showed using cultures of both primary bovine turbinate cells and monocyte-derived macrophages
that treatment of cells with IFN α/β after infection with a strain of ncpBVDV reduced the level of
viral RNA less than threefold compared to non-IFN-treated cells. In contrast, a very much greater
reduction in virus occurred if the IFN was added prior to infection. Another series of studies aimed at
determining how BVDV may induce foetal immune tolerance and the birth of PI calves has, however,
concluded that the action of any type 1 IFN present is not affected [47–49]. Upregulation of the type 1
IFN pathway genes including ISGs in response to BVDV were reported in both the maternal white
blood cells and in a variety of foetal tissues. These results clearly differed from ours as reported here
and previously [24] using endometrial cells, in which production of most ISG in response to IFNT was
inhibited by infection with type 1 ncpBVDV (although not entirely absent). The models used were,
however, very different. The in vitro studies used different cell types, while in the in vivo experiments
mid to late pregnant heifers were inoculated with ncpBVDV type 2 and then responses were measured
at various time intervals after infection. It should be noted that the foetus is immunologically immature
at this stage and also that our cultures did not contain white blood cells. Therefore, both the tissues
and the strains of BVDV tested differed in these various experiments. According to Peterhans and
Schweizer [42] responses of IFN signalling system to BVDV infection are known to differ between
organs and cell types. Our test model relates to maternal PR in which the conceptus is producing
significant amounts of IFNT over at least a two-week period and it is the direct action on the maternal
endometrial cells that matters. This suggests that the local immune mechanisms operating in the
uterus during the establishment of pregnancy differ to those involving either the maternal white blood
cells in circulation or the developing foetus later in gestation.
Our work has focussed mainly on type 1 interferons, however, type II interferon (IFNG) also plays
an important role in adaptive and innate immunity against both bacterial and viral infections. One of its
important signalling pathways is also through the action of JAK1 and STAT1 to form an IFNG-activated
factor [32] (see Figure 5a). In our present study, we used IFNG as a marker for general immune
responses. Neither JAK1 nor STAT1 expression was influenced by the treatment with ncpBVDV alone
whereas IFNG expression was enhanced. The increased IFNG expression suggests that the cultured
bovine endometrial cells retained some ability to offer a normal immune response to the viral infection.
With regard to the establishment of pregnancy, experiments performed primarily in sheep
showed that prostaglandins (PGs) produced by both the endometrium and the conceptus itself were
important in the establishment of pregnancy, and interacted with IFNT in regulating endometrial gene
expression [12,31]. In particular, ewes treated with IFNT had increased activity of the key enzyme
prostaglandin synthase, associated with higher levels of PGE2, PGF2α and 6-keto-PGF1α in the uterine
lumen. Furthermore, induction of a number of IFNT stimulated genes were inhibited when the animals
were co-treated with the PG synthase inhibitor meloxicam. This indicated that PGs act in concert with
IFNT to promote development of the conceptus. We, therefore, previously investigated the effects
of ncpBVDV and IFNT on PG synthesis in cultured bovine endometrium [23]. This showed that
ncpBVDV alone increased PGE2 endometrial synthesis while decreasing PGF2α, so increasing the
PGE2:PGF2α ratio. This was achieved by increasing expression of both PTGS1 and mPGES1, and would
be predicted to cause inflammatory changes such as stromal oedema and to promote maintenance
of the corpus luteum in the absence of a conceptus. When endometrial cells were treated with both
ncpBVDV and IFNT, the main PGF synthase AKRB1 was decreased, reducing synthesis of PGF2α and
endometrial expression of PTGER3 was inhibited. These changes are therefore likely to act in concert
with the alterations in the IFNT signalling pathway as described here to inhibit PR in cattle infected
with ncpBVDV (Figure 5b).
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Figure 5. During pregnancy recognition (PR) in cattle conceptus produced IFNT increased expression
of type I IFN-stimulated genes (ISGs) in the uterine endometrium and increased prostaglandin (PG)
production facilitates these effects [13]. Our previous work showed that when endometrial cells were
treated with both ncpBVDV and IFNT, then the increase in endometrial expression of most ISGs tested
(which normally accompanies maternal PR) was strongly inhibited [24]. (a) The present study has
extended these observations to investigate the upstream signalling pathways involved, notably the
combined treatment inhibited expression of TYK2, STAT1, STAT2 and IRF9. These are all crucial to
signalling of type 1 IFNs through the IFNARs and would explain why upregulation of many ISGs
inhibited ncpBVDV. Of these, only STAT1 is also required for signalling via IFNG and the IFNG
receptor, therefore this pathway is likely to be less affected by ncpBVDV. Following uptake of BVDV
into endometrial cells by endocytosis, the virus is initially incorporated into the endosome, where it
may be sensed by TLR3 or TLR7/8. For replication to occur, viral RNA then needs to be released into
the cytoplasm where it can also be detected by the cytoplasmic pattern recognition receptors DDX58
and IFIH1. These receptors signal via TRAF3 and IRF3 or IRF7 to increase cellular production of type 1
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IFN [50]. We showed previously [24] that ncpBVDV could inhibit the expression of DDX58 and
IFIH1, while the present results found inhibition of IRF7. The BVDV protein Npro targets IRF3
toward proteasomal degradation [44]. Therefore, this pathway is also inhibited by the presence of
ncpBVDV, therefore preventing the host from responding to the virus by producing type 1 IFN. Note
that the pictures of the virus indicate points in the pathway, which were downregulated in ncpBVDV
infected cells. These effects may have been indirect. Overall, these combined changes induced in the
endometrium by ncpBVD are likely to interfere with the normal pathways required for pregnancy
recognition. (b) With respect to PG production, epithelial cells predominantly synthesise PGF2α
whereas stromal cells produce most of the PGE2 and the conceptus itself synthesises a variety of PGs
including PGF2α, PGE2 and 6-keto-PGF1α. Both endometrial cells and the conceptus contain receptors
for both PGE and PGF. One of the key actions of IFNT in maternal pregnancy recognition is to block
the development of oxytocin receptors in the epithelium, therefore preventing PGF2α from being
released in large pulses, which can cause luteal regression [51]. Nevertheless, total PG production
increases substantially in early pregnancy [52]. Our previous work [23] has shown that infection of
endometrial cells with ncpBVDV alone increases PGE2 endometrial synthesis while decreasing PGF2α,
thus increasing the PGE2:PGF2α ratio. When endometrial cells were treated with both ncpBVDV
and IFNT, expression of the main PGF synthase AKRB1 was decreased, reducing synthesis of PGF2α
and endometrial expression of PTGER3, which was inhibited. These changes are likely to reduce the
required PG signalling within the endometrium during PR and have been shown to act in synergy with
IFNT [12,13].
5. Conclusions
In conclusion, our study showed that JAK/TYK2-STAT1 and STAT2–IRF signalling pathways play
central roles in MPR initiated by IFNT in cows and that ncpBVDV infection inhibited the activation of
IFNT on this pathway. Our study design did not distinguish between direct and indirect effects of the
virus so it is possible that the reduction in expression or activity of IRF-3/IRF-7 by viral Npro might
inhibit the positive feedback loop for IFN type-I expression that might be initiated by the addition of
IFNT. We demonstrated here that inhibition of this upstream signalling pathway for ISG production
was likely to disrupt MPR. In addition, the reduction of uterine immunity by ncpBVDV infection may
predispose the animals to uterine infection, which in turn would impair reproductive performance.
This provides a mechanism for how BVDV infection leads to PR failure in cows.
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